Skip to main content
. 2017 Nov 27;7:16365. doi: 10.1038/s41598-017-16555-3

Figure 2.

Figure 2

FAD104 expression is elevated during TGF-β–mediated EMT in NMuMG cells. NMuMG cells were treated with 5 ng/mL TGF-β1 or vehicle for 48 h. (A) Morphological changes in NMuMG cells after treatment with TGF-β1. F-actin was visualized by TRITC-conjugated phalloidin. (B) Expression of the epithelial marker ZO-1 and mesenchymal marker N-cadherin after treatment with TGF-β1. Whole-cell lysates were subjected to Western blot analysis and β-actin was used as a loading control. (C) qPCR analysis of fad104 expression in NMuMG cells treated with TGF-β1. The expression level of fad104 was normalized with 18 S rRNA expression. Each column represents the mean with standard deviation (n = 3). Significant differences are indicated as **p < 0.01. (D) Protein expression of FAD104 in NMuMG cells after treatment with TGF-β1. Whole-cell lysates were subjected to Western blot analysis and β-was used as a loading control.